Healthy men to test copycat cancer drug in early safety study
Knowledge-focused
Recruiting now
This study tests a new experimental drug called Bmab3000 against an approved drug, Herceptin Hylecta, in 150 healthy male volunteers. The goal is to see how the body absorbs and processes the new drug and whether it causes any side effects. Participants receive a single injection…
Phase: PHASE1 • Sponsor: Biocon Biologics UK PLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC